about
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localizationExpression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligandsOpioids and Viral Infections: A Double-Edged SwordDual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine-dependent miceKnockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in ratsKEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphineIt's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.Selective ligands for the mu, delta, and kappa opioid receptors identified from a single mixture based tetrapeptide positional scanning combinatorial library.Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.Delta opioid receptor on equine sperm cells: subcellular localization and involvement in sperm motility analyzed by computer assisted sperm analyzer (CASA).Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.Cardiac opioids.Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.Inhibition of passive-avoidance memory formation in the day-old chick by the opioid cytochrophin-4.Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamusDissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.Differential activation of G-proteins by mu-opioid receptor agonists.Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioidsEffect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.Modulating effect of the nootropic drug, piracetam on stress- and subsequent morphine-induced prolactin secretion in male rats.Opioids potentiate electrical transmission at mixed synapses on the Mauthner cell.Cellular mechanisms underlying neuronal excitability during morphine withdrawal in physical dependence: lessons from the magnocellular oxytocin system.Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms.Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors.Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsDifferential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.Estrogen and progesterone modulate [35S]GTPgammaS binding to nociceptin receptors.Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administrationReciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphineA novel Gbetagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence.Mu opioids and their receptors: evolution of a concept.Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.
P2860
Q24309094-1AED41CD-24D6-4425-BA5F-702BF3A5FD00Q24561648-A1E24BD5-682C-4D0C-8F87-1DC1B934C74AQ26742182-4FC3C70E-35C3-4015-8564-EA783973D7AEQ28298439-4F3E7146-64E6-4250-A139-C1D95B40A71EQ28345913-8CF55B23-ECA9-4E96-AAD1-341F598BB1C8Q28509333-D19535F8-A45A-4D6C-B81F-718C9A8BE414Q30437184-EBA729E2-0124-43BD-B7CC-FB59ABADD87FQ32052855-9218F55D-1289-4E1F-A9D5-78D652F8973FQ33582025-70AA7807-6C08-4856-88F9-9D911FD4831DQ33616823-29A7A86C-7312-4F86-84C0-D5593FA0E74CQ33640240-C607FDC4-5E88-4009-B291-A8EE9459E90DQ33899254-3CF3C0C8-41E1-4D4B-9CB6-8BD438A24B5EQ33976326-207A6EE4-DD0C-4D4E-B66C-30531068E636Q34039683-86640CDF-3950-4A3A-888F-4133D844498BQ34383670-CAF8C0D5-BBDC-45FC-9352-5B74E6C7B45AQ34388992-64D060A3-B3CF-4B63-BB51-272050FD861BQ35040255-67376786-D3E4-4154-82C1-A84366719A6CQ35042383-E20DB61F-F38A-4E42-9082-9A19AE3C5AC4Q35225923-F129B66B-D2D6-4E5A-B7E6-80383AED1C9FQ35243402-C60485F8-4505-4EF8-8BF3-0E28B7D76DAFQ35545366-45FA8796-0844-4108-B029-FC43CC0B3B35Q35621680-FA5761AC-C0FB-48D4-9274-D3646E15CB5CQ35682364-74B42763-5108-4265-ACA7-BC324A716C01Q35873290-A87AB0A5-42A7-4DFE-AE2F-4901CEBE52BCQ35881855-121F89F5-4B85-4F61-B536-51B3C7307F8BQ35932072-8ADCC734-5A1A-48DE-97F7-6AE308DBE976Q35952061-0AC0EADF-96F0-49FD-AFD5-82BD6F3DA733Q36089024-36A9AB96-9796-42EB-B300-B2924CDEE5B8Q36232833-6D9C2D57-C3D8-43F2-A465-8C834C133D5DQ36279301-288DE81C-651C-43DF-8646-DA6178D8CD45Q36358112-3BA86580-0C84-494F-9009-A710A6E5F9B1Q36431241-D97D39C1-1AE7-4F99-B9AC-A71278745C80Q36838054-F16E3413-2CC5-4436-844A-229C40CC5EC2Q36973583-3760DD3B-BFC8-45C0-8CA9-84849FF2BAEBQ37027306-DE407CDB-0230-4075-8F30-2F3EFFA82637Q37066352-90B4ED64-0FC5-4CD0-86C5-4B0F0D0E2D8BQ37089860-B0EE98C3-C6A2-42D8-8230-E271D3CED660Q37107564-7A77D504-880B-49E8-8EDA-A4E6D92A0EB4Q37236111-470B93EA-B82F-4FF5-A717-50E6343BB1FAQ37360643-6D712E54-FBE9-4008-B1CB-F8C3B1395F39
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Opioid receptor-coupled second messenger systems.
@en
Opioid receptor-coupled second messenger systems.
@nl
type
label
Opioid receptor-coupled second messenger systems.
@en
Opioid receptor-coupled second messenger systems.
@nl
prefLabel
Opioid receptor-coupled second messenger systems.
@en
Opioid receptor-coupled second messenger systems.
@nl
P1433
P1476
Opioid receptor-coupled second messenger systems.
@en
P2093
Childers SR
P304
P356
10.1016/0024-3205(91)90154-4
P407
P577
1991-01-01T00:00:00Z